The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Opthalmology Drugs and Devices Market Research Report 2025
Synopsis
Ophthalmology is a branch of medicine that deals with the anatomy, physiology, and diseases of the eye.
The global Opthalmology Drugs and Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Opthalmology Drugs and Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Opthalmology Drugs and Devices.
Report Scope
The Opthalmology Drugs and Devices market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Opthalmology Drugs and Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Opthalmology Drugs and Devices companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck (US)
Pfizer (US)
Roche Holdings (Switzerland)
Santen Pharmaceutical(Japan)
Alcon (Switzerland)
Bausch & Lomb (US)
Carl Zeiss Meditec (Germany)
Essilor International S.A. (France)
Johnson & Johnson (US)
Nidek(Japan)
Topcon Corporation (Japan)
Segment by Type
Device
Drug
Segment by Application
Hosptial
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Opthalmology Drugs and Devices companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Ophthalmology is a branch of medicine that deals with the anatomy, physiology, and diseases of the eye.
The global Opthalmology Drugs and Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Opthalmology Drugs and Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Opthalmology Drugs and Devices.
Report Scope
The Opthalmology Drugs and Devices market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Opthalmology Drugs and Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Opthalmology Drugs and Devices companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck (US)
Pfizer (US)
Roche Holdings (Switzerland)
Santen Pharmaceutical(Japan)
Alcon (Switzerland)
Bausch & Lomb (US)
Carl Zeiss Meditec (Germany)
Essilor International S.A. (France)
Johnson & Johnson (US)
Nidek(Japan)
Topcon Corporation (Japan)
Segment by Type
Device
Drug
Segment by Application
Hosptial
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Opthalmology Drugs and Devices companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Opthalmology Drugs and Devices Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Device
1.2.3 Drug
1.3 Market by Application
1.3.1 Global Opthalmology Drugs and Devices Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hosptial
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Opthalmology Drugs and Devices Market Perspective (2019-2030)
2.2 Opthalmology Drugs and Devices Growth Trends by Region
2.2.1 Global Opthalmology Drugs and Devices Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Opthalmology Drugs and Devices Historic Market Size by Region (2019-2024)
2.2.3 Opthalmology Drugs and Devices Forecasted Market Size by Region (2025-2030)
2.3 Opthalmology Drugs and Devices Market Dynamics
2.3.1 Opthalmology Drugs and Devices Industry Trends
2.3.2 Opthalmology Drugs and Devices Market Drivers
2.3.3 Opthalmology Drugs and Devices Market Challenges
2.3.4 Opthalmology Drugs and Devices Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Opthalmology Drugs and Devices Players by Revenue
3.1.1 Global Top Opthalmology Drugs and Devices Players by Revenue (2019-2024)
3.1.2 Global Opthalmology Drugs and Devices Revenue Market Share by Players (2019-2024)
3.2 Global Opthalmology Drugs and Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Opthalmology Drugs and Devices Revenue
3.4 Global Opthalmology Drugs and Devices Market Concentration Ratio
3.4.1 Global Opthalmology Drugs and Devices Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Opthalmology Drugs and Devices Revenue in 2023
3.5 Opthalmology Drugs and Devices Key Players Head office and Area Served
3.6 Key Players Opthalmology Drugs and Devices Product Solution and Service
3.7 Date of Enter into Opthalmology Drugs and Devices Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Opthalmology Drugs and Devices Breakdown Data by Type
4.1 Global Opthalmology Drugs and Devices Historic Market Size by Type (2019-2024)
4.2 Global Opthalmology Drugs and Devices Forecasted Market Size by Type (2025-2030)
5 Opthalmology Drugs and Devices Breakdown Data by Application
5.1 Global Opthalmology Drugs and Devices Historic Market Size by Application (2019-2024)
5.2 Global Opthalmology Drugs and Devices Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Opthalmology Drugs and Devices Market Size (2019-2030)
6.2 North America Opthalmology Drugs and Devices Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Opthalmology Drugs and Devices Market Size by Country (2019-2024)
6.4 North America Opthalmology Drugs and Devices Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Opthalmology Drugs and Devices Market Size (2019-2030)
7.2 Europe Opthalmology Drugs and Devices Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Opthalmology Drugs and Devices Market Size by Country (2019-2024)
7.4 Europe Opthalmology Drugs and Devices Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Opthalmology Drugs and Devices Market Size (2019-2030)
8.2 Asia-Pacific Opthalmology Drugs and Devices Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Opthalmology Drugs and Devices Market Size by Region (2019-2024)
8.4 Asia-Pacific Opthalmology Drugs and Devices Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Opthalmology Drugs and Devices Market Size (2019-2030)
9.2 Latin America Opthalmology Drugs and Devices Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Opthalmology Drugs and Devices Market Size by Country (2019-2024)
9.4 Latin America Opthalmology Drugs and Devices Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Opthalmology Drugs and Devices Market Size (2019-2030)
10.2 Middle East & Africa Opthalmology Drugs and Devices Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Opthalmology Drugs and Devices Market Size by Country (2019-2024)
10.4 Middle East & Africa Opthalmology Drugs and Devices Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck (US)
11.1.1 Merck (US) Company Detail
11.1.2 Merck (US) Business Overview
11.1.3 Merck (US) Opthalmology Drugs and Devices Introduction
11.1.4 Merck (US) Revenue in Opthalmology Drugs and Devices Business (2019-2024)
11.1.5 Merck (US) Recent Development
11.2 Pfizer (US)
11.2.1 Pfizer (US) Company Detail
11.2.2 Pfizer (US) Business Overview
11.2.3 Pfizer (US) Opthalmology Drugs and Devices Introduction
11.2.4 Pfizer (US) Revenue in Opthalmology Drugs and Devices Business (2019-2024)
11.2.5 Pfizer (US) Recent Development
11.3 Roche Holdings (Switzerland)
11.3.1 Roche Holdings (Switzerland) Company Detail
11.3.2 Roche Holdings (Switzerland) Business Overview
11.3.3 Roche Holdings (Switzerland) Opthalmology Drugs and Devices Introduction
11.3.4 Roche Holdings (Switzerland) Revenue in Opthalmology Drugs and Devices Business (2019-2024)
11.3.5 Roche Holdings (Switzerland) Recent Development
11.4 Santen Pharmaceutical(Japan)
11.4.1 Santen Pharmaceutical(Japan) Company Detail
11.4.2 Santen Pharmaceutical(Japan) Business Overview
11.4.3 Santen Pharmaceutical(Japan) Opthalmology Drugs and Devices Introduction
11.4.4 Santen Pharmaceutical(Japan) Revenue in Opthalmology Drugs and Devices Business (2019-2024)
11.4.5 Santen Pharmaceutical(Japan) Recent Development
11.5 Alcon (Switzerland)
11.5.1 Alcon (Switzerland) Company Detail
11.5.2 Alcon (Switzerland) Business Overview
11.5.3 Alcon (Switzerland) Opthalmology Drugs and Devices Introduction
11.5.4 Alcon (Switzerland) Revenue in Opthalmology Drugs and Devices Business (2019-2024)
11.5.5 Alcon (Switzerland) Recent Development
11.6 Bausch & Lomb (US)
11.6.1 Bausch & Lomb (US) Company Detail
11.6.2 Bausch & Lomb (US) Business Overview
11.6.3 Bausch & Lomb (US) Opthalmology Drugs and Devices Introduction
11.6.4 Bausch & Lomb (US) Revenue in Opthalmology Drugs and Devices Business (2019-2024)
11.6.5 Bausch & Lomb (US) Recent Development
11.7 Carl Zeiss Meditec (Germany)
11.7.1 Carl Zeiss Meditec (Germany) Company Detail
11.7.2 Carl Zeiss Meditec (Germany) Business Overview
11.7.3 Carl Zeiss Meditec (Germany) Opthalmology Drugs and Devices Introduction
11.7.4 Carl Zeiss Meditec (Germany) Revenue in Opthalmology Drugs and Devices Business (2019-2024)
11.7.5 Carl Zeiss Meditec (Germany) Recent Development
11.8 Essilor International S.A. (France)
11.8.1 Essilor International S.A. (France) Company Detail
11.8.2 Essilor International S.A. (France) Business Overview
11.8.3 Essilor International S.A. (France) Opthalmology Drugs and Devices Introduction
11.8.4 Essilor International S.A. (France) Revenue in Opthalmology Drugs and Devices Business (2019-2024)
11.8.5 Essilor International S.A. (France) Recent Development
11.9 Johnson & Johnson (US)
11.9.1 Johnson & Johnson (US) Company Detail
11.9.2 Johnson & Johnson (US) Business Overview
11.9.3 Johnson & Johnson (US) Opthalmology Drugs and Devices Introduction
11.9.4 Johnson & Johnson (US) Revenue in Opthalmology Drugs and Devices Business (2019-2024)
11.9.5 Johnson & Johnson (US) Recent Development
11.10 Nidek(Japan)
11.10.1 Nidek(Japan) Company Detail
11.10.2 Nidek(Japan) Business Overview
11.10.3 Nidek(Japan) Opthalmology Drugs and Devices Introduction
11.10.4 Nidek(Japan) Revenue in Opthalmology Drugs and Devices Business (2019-2024)
11.10.5 Nidek(Japan) Recent Development
11.11 Topcon Corporation (Japan)
11.11.1 Topcon Corporation (Japan) Company Detail
11.11.2 Topcon Corporation (Japan) Business Overview
11.11.3 Topcon Corporation (Japan) Opthalmology Drugs and Devices Introduction
11.11.4 Topcon Corporation (Japan) Revenue in Opthalmology Drugs and Devices Business (2019-2024)
11.11.5 Topcon Corporation (Japan) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
